July 11, 2016 / 8:54 PM / in a year

BRIEF-Intelgenx Technologies announces notice of appeal for Buprenorphine/Naloxone

July 11 (Reuters) - Intelgenx Technologies Corp :

* Intelgenx announces notice of appeal for buprenorphine/naloxone sublingual film product for the treatment of opiate addiction

* Court ruled par’s anda product would infringe asserted claims of u.s. Patent no. 8,603,514

* Court rule one of orange book listed patents for suboxone film, claims of u.s. Patent no. 8,603,514 were not shown to be invalid Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below